Basch, E., Reeve, B. B., Mitchell, S. A., Clauser, S. B., Minasian, L. M., Dueck, A. C., Mendoza, T. R., Hay, J., Atkinson, T. M., Abernethy, A. P., Bruner, D. W., Cleeland, C. S., Sloan, J. A., Chilukuri, R., Baumgartner, P., Denicoff, A., St Germain, D., O’Mara, A. M., Chen, A., et al. (2014). Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/dju244

Article  PubMed  PubMed Central  Google Scholar 

Atkinson, T. M., Hay, J. L., Dueck, A. C., Mitchell, S. A., Mendoza, T. R., Rogak, L. J., Minasian, L. M., & Basch, E. (2018). What do “none,” “mild,” “moderate,” “severe,” and “very severe” mean to patients with cancer? Content validity of PRO-CTCAE response scales. Journal of Pain and Symptom Management, 55(3), e3–e6. https://doi.org/10.1016/j.jpainsymman.2017.10.024

Article  PubMed  Google Scholar 

Lee, M. K., Peipert, J. D., Cella, D., Yost, K. J., Eton, D. T., Novotny, P. J., Sloan, J. A., & Dueck, A. C. (2023). Identifying meaningful change on PROMIS short forms in cancer patients: A comparison of item response theory and classic test theory frameworks. Quality of Life Research, 32(5), 1355–1367. https://doi.org/10.1007/s11136-022-03255-3

Article  PubMed  Google Scholar 

Bell, M. L., Dhillon, H. M., Bray, V. J., & Vardy, J. L. (2018). Important differences and meaningful changes for the functional assessment of cancer therapy-cognitive function (FACT-Cog). Journal of PAtient Reported Outcomes. https://doi.org/10.1186/s41687-018-0071-4

Article  PubMed Central  Google Scholar 

Hudgens, S., Ramage, J., Kulke, M., Bergsland, E., Anthony, L., Caplin, M., Oberg, K., Pavel, M., Gable, J., Banks, P., Yang, Q. M., & Lapuerta, P. (2019). Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome. Journal of Patient-Reported Outcomes, 3(1), 64. https://doi.org/10.1186/s41687-019-0153-y

Article  PubMed  PubMed Central  Google Scholar 

de Vet, H. C., Terluin, B., Knol, D. L., Roorda, L. D., Mokkink, L. B., Ostelo, R. W., Hendriks, E. J., Bouter, L. M., & Terwee, C. B. (2010). Three ways to quantify uncertainty in individually applied “minimally important change” values. Journal of Clinical Epidemiology, 63(1), 37–45. https://doi.org/10.1016/j.jclinepi.2009.03.011

Article  PubMed  Google Scholar 

Terluin, B., Eekhout, I., & Terwee, C. B. (2017). The anchor-based minimal important change, based on receiver operating characteristic analysis or predictive modeling, may need to be adjusted for the proportion of improved patients. Journal of Clinical Epidemiology, 83, 90–100. https://doi.org/10.1016/j.jclinepi.2016.12.015

Article  PubMed  Google Scholar 

Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J. S., Terluin, B., Cella, D., Griffiths, P., & Mokkink, L. B. (2021). Minimal important change (MIC): A conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of Life Research, 30(10), 2729–2754. https://doi.org/10.1007/s11136-021-02925-y

Article  PubMed  PubMed Central  Google Scholar 

Giesinger, J. M., Kieffer, J. M., Fayers, P. M., Groenvold, M., Petersen, M. A., Scott, N. W., Sprangers, M. A., Velikova, G., Aaronson, N. K., EORTC Quality of Life Group. (2016). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology, 69, 79–88. https://doi.org/10.1016/j.jclinepi.2015.08.007

Article  PubMed  Google Scholar 

Husson, O., de Rooij, B. H., Kieffer, J., Oerlemans, S., Mols, F., Aaronson, N. K., van der Graaf, W. T. A., & van de Poll-Franse, L. V. (2020). The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with cancer in the “real-world”: Results from the population-based PROFILES registry. The Oncologist, 25(4), E722–E732. https://doi.org/10.1634/theoncologist.2019-0348

Article  PubMed  Google Scholar 

Kasper, B. (2020). The EORTC QLQ-C30 summary score as a prognostic factor for survival of patients with cancer: A commentary. The Oncologist, 25(4), E610–E611. https://doi.org/10.1634/theoncologist.2019-0749

Article  PubMed  PubMed Central  Google Scholar 

Dueck, A. C., Mendoza, T. R., Mitchell, S. A., Reeve, B. B., Castro, K. M., Rogak, L. J., Atkinson, T. M., Bennett, A. V., Denicoff, A. M., O’Mara, A. M., Li, Y., Clauser, S. B., Bryant, D. M., Bearden, J. D., 3rd., Gillis, T. A., Harness, J. K., Siegel, R. D., Paul, D. B., Cleeland, C. S., et al. (2015). Validity and reliability of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncology, 1(8), 1051–1059. https://doi.org/10.1001/jamaoncol.2015.2639

Article  PubMed  PubMed Central  Google Scholar 

Cleeland, C. S., Zhao, F., Chang, V. T., Sloan, J. A., O’Mara, A. M., Gilman, P. B., Weiss, M., Mendoza, T. R., Lee, J. W., & Fisch, M. J. (2013). The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer, 119(24), 4333–4340. https://doi.org/10.1002/cncr.28376

Article  PubMed  Google Scholar 

Reeve, B. B., Mitchell, S. A., Dueck, A. C., Basch, E., Cella, D., Reilly, C. M., Minasian, L. M., Denicoff, A. M., O’Mara, A. M., Fisch, M. J., Chauhan, C., Aaronson, N. K., Coens, C., & Bruner, D. W. (2014). Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/dju129

Article  PubMed  PubMed Central  Google Scholar 

Basch, E., Schrag, D., Henson, S., Jansen, J., Ginos, B., Stover, A. M., Carr, P., Spears, P. A., Jonsson, M., Deal, A. M., Bennett, A. V., Thanarajasingam, G., Rogak, L. J., Reeve, B. B., Snyder, C., Bruner, D., Cella, D., Kottschade, L. A., Perlmutter, J., et al. (2022). Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: A randomized clinical trial. JAMA, 327(24), 2413–2422. https://doi.org/10.1001/jama.2022.9265

Article  PubMed  PubMed Central  Google Scholar 

Ousmen, A., Touraine, C., Deliu, N., Cottone, F., Bonnetain, F., Efficace, F., Bredart, A., Mollevi, C., & Anota, A. (2018). Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: A structured review. Health and Quality of Life Outcomes, 16(1), 228. https://doi.org/10.1186/s12955-018-1055-z

Article  PubMed  PubMed Central  Google Scholar 

Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102–109. https://doi.org/10.1016/j.jclinepi.2007.03.012

Article  PubMed  Google Scholar 

Coon, C. D., Schlichting, M., & Zhang, X. K. (2022). Interpreting within-patient changes on the EORTC QLQ-C30 and EORTC QLQ-LC13. Patient-Patient Centered Outcomes Research, 15(6), 691–702. https://doi.org/10.1007/s40271-022-00584-w

Article  PubMed  Google Scholar 

Terluin, B., Eekhout, I., Terwee, C. B., & de Vet, H. C. (2015). Minimal important change (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis. Journal of Clinical Epidemiology, 68(12), 1388–1396. https://doi.org/10.1016/j.jclinepi.2015.03.015

Article  PubMed  Google Scholar 

Basch, E., Becker, C., Rogak, L. J., Schrag, D., Reeve, B. B., Spears, P., Smith, M. L., Gounder, M. M., Mahoney, M. R., Schwartz, G. K., Bennett, A. V., Mendoza, T. R., Cleeland, C. S., Sloan, J. A., Bruner, D. W., Schwab, G., Atkinson, T. M., Thanarajasingam, G., Bertagnolli, M. M., & Dueck, A. C. (2021). Composite grading algorithm for the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Clinical Trials, 18(1), 104–114. https://doi.org/10.1177/1740774520975120

Article  PubMed  Google Scholar 

Mazza, G. L., Dueck, A. C., Ginos, B., Jansen, J., Deal, A. M., Carr, P., Blinder, V. S., Thanarajasingam, G., Jonsson, M., Lee, M. K., Rogak, L. J., Mody, G. N., Schrag, D., & Basch, E. (2024). Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39). Quality of Life Research, 33(7), 1985–1995. https://doi.org/10.1007/s11136-024-03675-3

Article  PubMed  Google Scholar 

Cocks, K., & Buchanan, J. (2023). How scoring limits the usability of minimal important differences (MIDs) as responder definition (RD): An exemplary demonstration using EORTC QLQ-C30 subscales. Quality of Life Research, 32(5), 1247–1253. https://doi.org/10.1007/s11136-022-03181-4

Article  PubMed  Google Scholar 

U.S. Food and Drug Administration. (2022). Patient-focused drug development: Methods to identify what is important to patients guidance for industry, food and drug administration staff, and other stakeholders. Retrieved from https://www.fda.gov/media/131230/download.

U.S. Food and Drug Administration. (2023). Patient-focused drug development: Incorporating clinical outcome assessments into endpoints for regulatory decision-making guidance for industry, food and drug administration staff, and other stakeholders (draft guidance). Retrieved from https://www.fda.gov/media/166830/download.

Cardellino, A., Shah, M., Hanlon, J., Kelly, K., Martin, A., Roborel de Climens, A., Taiyari, S., & Stojadinovic, A. (2023). Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: A qualitative research study. Frontiers in Psychology, 14, 1217793. https://doi.org/10.3389/fpsyg.2023.1217793

Article  PubMed  PubMed Central  Google Scholar 

Coon, C. D., & Cappelleri, J. C. (2016). Interpreting change in scores on patient-reported outcome instruments. Therapeutic Innovation & Regulatory Science, 50(1), 22–29. https://doi.org/10.1177/2168479015622667

Article  Google Scholar 

Mc Carthy, M., Burrows, K., Griffiths, P., Black, P. M., Demanuele, C., Karlsson, N., Buenconsejo, J., Patel, N., Chen, W. H., & Cappelleri, J. C. (2023). From meaningful outcomes to meaningful change thresholds: A path to progress for establishing digital endpoints. Therapeutic Innovation & Regulatory Science, 57(4), 629–645. https://doi.org/10.1007/s43441-023-00502-8

Article  Google Scholar 

Staunton, H., Willgoss, T., Nelsen, L., Burbridge, C., Sully, K., Rofail, D., & Arbuckle, R. (2019). An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments. Journal of Patient-Reported Outcomes, 3(1), 16. https://doi.org/10.1186/s41687-019-0100-y